PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

Accessibility StatementSkip Navigation WARREN, N.J., Nov. 4, 2025 /PRNewswire/ -- PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced a corporate update and financial results for the third quarter ended September 30, 2025. Key Corporate Updates Key Clinical and Regulatory Updates Third Quarter 2025 Financial Highlights PTC Full-Year 2025 Financial Guidance For the full year 2025, PTC anticipates: Total revenue of $750 to $800 million, which includes in-line products and royalty revenue from Evrysdi.  ...